Cite
HARVARD Citation
Pica, R. et al. (2015). A randomized trial comparing 4.8 vs. 2.4 g/day of oral mesalazine for maintenance of remission in ulcerative colitis. Digestive and liver disease. 47 (11), pp. 933-937. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pica, R. et al. (2015). A randomized trial comparing 4.8 vs. 2.4 g/day of oral mesalazine for maintenance of remission in ulcerative colitis. Digestive and liver disease. 47 (11), pp. 933-937. [Online].